Clinical Scorecard: Comparison of Transradial and Transfemoral Neuroangiography in a Tertiary Pediatric Setting: A Propensity Score Matched Analysis
At a Glance
Category
Detail
Condition
Pediatric neurovascular diseases requiring neuroangiography or endovascular neurointerventions
Key Mechanisms
Transradial access (TRA) and transfemoral access (TFA) for arterial catheterization during neuroangiographic procedures
Target Population
Patients aged 18 years or below undergoing neurovascular procedures
Care Setting
Tertiary pediatric hospital neurointerventional suite
Key Highlights
TRA is increasingly adopted in adults but remains less common in pediatrics due to smaller vessel size and risk concerns.
Corrected radial artery diameter approaches adult size by age 12, supporting feasibility of TRA in older children.
TRA allows immediate ambulation post-procedure, whereas TFA requires 4–6 hours of bed rest.
Guideline-Based Recommendations
Diagnosis
Preprocedural ultrasound assessment of radial artery anatomy and diameter is essential before TRA.
Exclude patients with high brachial artery bifurcation or stenosed/occluded radial artery from TRA.
Use corrected artery diameter and sheath-to-artery ratio (<1.5) to select appropriate candidates for TRA.
Management
Administer radial cocktail (Heparin, Nitroglycerin, Verapamil) via sheath during TRA to reduce vasospasm and thrombosis risk.
Use ultrasound guidance for arterial access in both TRA and TFA to improve safety.
Apply inflatable compression devices with patent hemostasis monitoring after TRA; manual compression after TFA.
Allow immediate ambulation after TRA; enforce 4–6 hours bed rest after TFA.
Monitoring & Follow-up
Assess radial artery pulse and hand perfusion prior to discharge after TRA.
Monitor femoral artery pulse and lower limb perfusion before discharge after TFA.
Use pulse oximetry on thumb (TRA) or big toe (TFA) during hemostasis to ensure distal perfusion.
Risks
TRA risks include radial artery occlusion, vasospasm, dissection, and thrombosis, especially in smaller or anomalous arteries.
TFA risks include higher complication rates with vascular closure devices in pediatric patients.
High brachial artery bifurcation increases vascular complication risk and contraindicates TRA.
Patient & Prescribing Data
Pediatric patients (≤18 years) undergoing neuroangiography or neurointervention
TRA is feasible and safe in selected pediatric patients with adequate radial artery size and anatomy; it offers advantages in patient comfort and recovery time compared to TFA.
Clinical Best Practices
Perform shared decision-making with patients and caretakers regarding access route selection.
Use preprocedural ultrasound to evaluate radial artery anatomy and measure corrected diameter.
Avoid TRA in patients with sheath-to-artery ratio ≥1.5 or high brachial artery bifurcation.
Administer intra-arterial vasodilators and anticoagulants during TRA to minimize complications.
Use patent hemostasis technique with compression devices post-TRA to preserve radial artery patency.
Allow immediate ambulation after TRA to enhance patient comfort and reduce hospital stay.
Monitor vascular access site pulses and distal perfusion before discharge to detect complications early.
